# adivo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adivo

- Industry: Biotechnology
- Headquarters: Munich, Germany
- Website: www.adivo.vet
- Latest round: Seed (Aug 20, 2018)
- Investors on record: 3

## About

Based in Germany, adivo GmbH develops innovative veterinary solutions aimed at enhancing animal health through advanced technology and therapeutic options.adivo GmbH is a veterinary technology company that focuses on developing therapeutic solutions for companion animals. Founded in Munich, Germany in 2018, the firm has undergone two notable deals since its inception. The latest deal was on September 15, 2023, when Zoetis Inc. acquired adivo GmbH from High-Tech Gründerfonds, Morphosys, and Occident Group. The founder's specific history is not available.adivo GmbH specializes in providing veterinary technologies and therapeutic solutions for animals. Their products are aimed at improving health outcomes in companion animals through innovative treatments and diagnostic tools. The company focuses on research and development to enhance their offerings in the veterinary sector.Details regarding revenue specifically for adivo GmbH are not provided, however, their business model likely involves collaborations with veterinary practitioners and animal health distributors to facilitate the distribution of their products.Following its acquisition by Zoetis Inc. in September 2023, adivo GmbH aims to leverage Zoetis's resources to enhance the development of therapeutic antibody medications for companion animals. This acquisition is expected to support their expansion into new markets and improve their innovative offerings.

## Funding rounds

- Seed, Aug 20, 2018 — High-Tech Gruenderfonds, MorphoSys AG, Occident Group

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- MorphoSys AG — Seed
- Occident Group — Seed